Successful treatment of cutaneous leishmaniasis using combined Lumenis ablative fractional laser resurfacing with laser-assisted delivery of topical paromomycin

On Jan. 1, Lee Dubay of BioOptics World reported that in a pilot study conducted by researchers at UC San Diego Medical school found that the combined treatment ofablative fractional laser resurfacing with laser-assisted delivery of topical paromomycin (an antibiotic) was effective in treating cutaneous leishmaniasis, a skin infection caused by a single-celled parasite that is transmitted by the bite of a phlebotomine sandfly.

ReWalk Robotics Secures Line of Credit of Up to $20 Million to Support Market Building Activities

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Jan. 04, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced that it has entered into an agreement with Kreos Capital V (Expert Fund) Limited (“Kreos”) for a line of credit of up to $20 million.  ReWalk drew down an initial tranche of $12 million. An additional $8 million dollars will be available in separate tranches subject to certain conditions, with a minimum drawdown of $2 million per tranche.

Under the terms of the agreement, interest-only payments will be due for the first 12 months at a rate of 10.75% per annum. Thereafter, monthly principal and interest payments will be due through the December 2018 maturity date, which can be extended by an additional 12 months subject to certain conditions. 

Additionally, Kreos was issued a warrant in the aggregate amount of $1.15 million to purchase ordinary shares of the Company (“Ordinary Shares”) at an exercise price of $9.64 per share, which represented the average of the closing prices of the Ordinary Shares for the thirty-day calendar period prior to the date of the issuance of the warrant, subject to adjustment as set forth in the warrant.  In the event the Company draws down any additional funds subsequent to the first tranche, the warrant amount will be increased by 5.75% of any such additional draw downs.

“This debt financing agreement provides added funding to support our growth and strategic initiatives,” said Larry Jasinski, Chief Executive Officer.  “We remain focused on increasing sales and market penetration and are encouraged by the growing market acceptance of the ReWalk Personal and Rehabilitation systems by end users and coverage providers alike. We expect to use this increased financial flexibility to advance our strategic market development and reimbursement activities to build long-term shareholder value,” he added.

Proceeds from the financing will be used for working capital and market expansion.  Armentum Partners acted as financial advisor to the Company in conjunction with this financing.

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. ReWalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.  For more information on the ReWalk systems, please visit http://www.rewalk.com.

Forward Looking Statements

This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, as amended and other securities laws. Forward-looking statements are statements that are not historical facts. Words such as “expect(s),” “feel(s),” “believe(s),” “will,” “may,” “intends,” “anticipate(s),” “look forward,” “upcoming,” “plan,” “enables,” “potentially,” “entitles,” and similar expressions are intended to identify forward-looking statements. All such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of the Company, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include, but are not limited to the following: the market for medical exoskeletons is new and unproven, and important assumptions about the potential market for ReWalk’s products may be inaccurate; the Company has a limited operating history upon which you can evaluate its business plan and prospects; if ReWalk is unable to expand its sales, marketing and training infrastructure, it may fail to increase its sales; the health benefits of ReWalk have not been substantiated by long-term clinical data, which could limit sales; the Company may fail to secure or retain adequate coverage or reimbursement for ReWalk by third-party payers; the Company depends on a single third-party to manufacture ReWalk and a limited number of third-party suppliers for certain components of ReWalk; the Company’s future growth and operating results will depend on its ability to develop and commercialize new products and penetrate new markets; the Company operates in a competitive industry that is subject to rapid technological change, and we expect competition to increase; and the Company is subject to extensive governmental regulations relating to the manufacturing, labeling and marketing of its products. These and other risk factors are set forth in the Company’s final Annual Report on Form 20-F for the year-ended December 31, 2014 filed with the Securities and Exchange Commission on February 27, 2015, and the Company’s other reports filed from time to time with the Securities and Exchange Commission.  Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.  ReWalk does not undertake any obligation to revise and disseminate forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of or non-occurrence of any events.

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.

Mellanox Technologies, Ltd. Schedules Release of Fourth Quarter 2015 Financial Results and Conference Call for January 27, 2016

SUNNYVALE, CA. and YOKNEAM, ISRAEL - January 4, 2016 - Mellanox(r) Technologies, Ltd. (NASDAQ: MLNX), a leading supplier of high-performance, end-to-end interconnect solutions for data center servers and storage systems, today announced that it will release its financial results for the fourth quarter 2015 after the market closes on Wednesday, January 27, 2016.

Following the release, Mellanox will conduct a conference call at 2 p.m. Pacific Time (5 p.m. Eastern Time). To listen to the call, dial +1-785-424-1666 approximately ten minutes prior to the start time.

The Mellanox financial results conference call will be available via a live webcast on the investor relations section of the Mellanox website at http://ir.mellanox.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will also be available on the Mellanox website.

About Mellanox Mellanox Technologies is a leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage. Mellanox interconnect solutions increase data center efficiency by providing the highest throughput and lowest latency, delivering data faster to applications and unlocking system performance capability. Mellanox offers a choice of fast interconnect products: adapters, switches, software, cables and silicon that accelerate application runtime and maximize business results for a wide range of markets including high-performance computing, enterprise data centers, Web 2.0, cloud, storage and financial services. More information is available at www.mellanox.comhttp://www.mellanox.com.

Mellanox is a registered trademark of Mellanox Technologies, Ltd. All other trademarks are property of their respective owners.

VA to pay for ReWalk Robotics' exoskeleton device for paralyzed veterans

VA to pay for ReWalk Robotics' exoskeleton device for paralyzed veterans

Emily Wasserman of Fierce Medical Devices reports that the U.S. Department of Veterans Affairs (VA) has decided to pay for the ReWalk exoskeleton for paralyzed veterans with spinal cord injuries after evaluating the system on 45 paralyzed veterans who fit the height and weight requirements. According the article, the studies found that paraplegics who used the exoskeleton as little as four hours a week for three to 5 months had better bowel and bladder function, less back pain and fatigue and improved sleep.

Resin Producer Lawter Triples Storage Performance With Zadara Storage

Resin Producer Lawter Triples Storage Performance With Zadara Storage

Zadara Storage Ltd, a provider of enterprise storage-as-a-service (STaaS), announced that Lawter, a subsidiary of the Japanese company Harima Chemicals Group, Inc. , has replaced their IBM storage with its Virtual Private Storage Array (VPSA) architecture to support their SAP applications worldwide.

Mellanox 10/40 Gigabit Ethernet Switches Approved for Use in U.S. Department of Defense Networks

Mellanox Federal Systems Awarded Unified Capabilities Approved Product List Certification by the Defense Information Systems Agency

SUNNYVALE, CA. and YOKNEAM, ISRAEL - December 14, 2015 - Mellanox(r) Technologies, Ltd. (NASDAQ: MLNX), a leading supplier of high-performance, end-to-end interconnect solutions for data center servers and storage systems, today announced the Defense Information Systems Agency (DISA) has approved the Mellanox SwitchX(r) series of 10/40 Gigabit Ethernet switches for use on U.S. Department of Defense (DoD) networks. This move comes as a direct result of the DISA awarding Mellanox Federal Systems the Unified Capabilities Approved Product List (UC APL) certification for the Mellanox SwitchX series of Ethernet switches.

"Federal agencies of the U.S. government, specifically the Department of Defense, require the most advanced and high-performance networking solutions available," said Dale D'Alessio, CEO of Mellanox Federal Systems. "These solutions must also adhere to the strictest security requirements to ensure data protection and guarantee that their system is up and running at all times. The UC APL certification is the latest confirmation that Mellanox has become the leading provider of the world's fastest and most flexible Ethernet interconnect solutions that can be trusted by federal agencies to deliver unrivaled security and accelerated performance for their data centers."

This UC APL certification is mandatory for all switch hardware to be sold for use on DoD programs of record and is testimony to the rapidly expanding success of Mellanox's Ethernet switches being approved for use on large DoD tactical programs. The certification ensures that Mellanox Ethernet hardware can be utilized for the production system of the DoD network and also grants the hardware recognition from additional federal agencies and foreign governments.

The following Mellanox SwitchX series of Ethernet switches are included in the UC APL certification: SX1012, SX1016, SX1024, SX1036, SX1400, SX1700, SX1710, SX6012, SX6012_WT, SX6018, SX6036, SX6036G and SX6710.

Mellanox Federal Systems is a wholly owned subsidiary of Mellanox Technologies, Inc. Mellanox has supported the government's IT networking needs for more than 15 years and has become a trusted leader in delivering high-performance connectivity solutions to many government agencies and organizations including the Department of Energy, NASA (Ames, Goddard and Johnson), U.S. Army, U.S. Navy, U.S. Air Force, U.S. Postal Service, FBI, DHS, NIH, the EPA and various intelligence agencies.

About Mellanox Mellanox Technologies is a leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage. Mellanox interconnect solutions increase data center efficiency by providing the highest throughput and lowest latency, delivering data faster to applications and unlocking system performance capability. Mellanox offers a choice of fast interconnect products: adapters, switches, software, cables and silicon that accelerate application runtime and maximize business results for a wide range of markets including high-performance computing, enterprise data centers, Web 2.0, cloud, storage and financial services. More information is available at www.mellanox.comhttp://www.mellanox.com.

Mellanox is a registered trademark of Mellanox Technologies, Ltd. All other trademarks are property of their respective owners.


Allyson Scott Account Supervisor

[cid:image001.gif@01C8E020.BD30DAD0]

333 W. San Carlos Street #900 San Jose, CA 95110

[cid:image002.jpg@01C8E020.BD30DAD0] (408) 727-0351 ext 784 [cid:image004.jpg@01C8E020.BD30DAD0] (408) 885-9317 fax

www.mcgrathpower.comhttp://www.mcgrathpower.com/ | Pass the Michttp://www.mcgrathpower.com/blog/ | Twitterhttps://twitter.com/mcgrathpowerpr | Facebookhttp://www.facebook.com/pages/San-Jose-CA/McGrathPower-Public-Relations-and-Communications/63116841459 | LinkedInhttps://www.linkedin.com/company/mcgrathpower-public-relations?trk=biz-companies-cym

Partner Agency, The Worldcom Group

CONFIDENTIALITY: The information contained in this email message is intended for the personal and confidential use of the designated recipient(s) named above. This message is intended to be a confidential communication and may involve information or material which is protected under State or Federal privacy laws. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this document in error and that any review, dissemination, distribution or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by phone and return this message to us via email.